Hepatitis Monthly

Papers
(The H4-Index of Hepatitis Monthly is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Potentiation of Apoptotic Effect of Combination of Etoposide and Quercetin on HepG2 Liver Cancer Cells20
Meta-analysis of the Correlation Between Cognitive Function and Imaging Features in Hepatic Encephalopathy10
Effectiveness and Safety of Tenofovir Alafenamide in Treatment-Naïve and Treatment-Experienced Patients with Chronic Hepatitis B: Results of a Real-World Study from China9
Analysis of the Effects of the WeChat Health Management Platform on the Self-care Ability and Quality of Life of Patients with Liver Cancer Undergoing Interventional Therapy9
Comparison of Tenofovir Alafenamide and Entecavir Therapy in Patients with Chronic Hepatitis B Initially Treated with Tenofovir Disoproxil: A Retrospective Observational Survey5
0.059870958328247